Leif William Ellisen, MD, PhD
Associate Physician, MGH Cancer Center
Clinical Director, Breast and Ovarian Cancer Genetics
Co-Executive Director, MGH Cancer Center Translational Research Laboratory
- Departments
- Hematology/Oncology
- Department of Medicine
Specialties
- Cancer Center
- Cancer Risk Assessment
- Breast Cancer
- Clinical Interests
- Cancer genetics
- Breast cancer
- Locations
- Boston: Massachusetts General Hospital
- Medical Education
- MD, PhD, Stanford University School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Dana-Farber Cancer Institute
- Accepting New Patients
- Yes
- Insurances Accepted
- Aetna Health Inc.
Beech Street
Best Doctors
Blue Cross Blue Shield - Blue Care 65
Blue Cross Blue Shield - Indemnity
Blue Cross Blue Shield - Managed Care
Blue Cross Blue Shield - Partners Plus
Centene/Celticare
Cigna (PAL #'s)
Cigna/Healthsource NH
EverCare
Fallon Community HealthCare
ForMost Managed Care
Great-West Healthcare (formally One Health Plan)
Harvard Pilgrim Health Plan - ACD
Harvard Pilgrim Health Plan - PBO
Health Care Value Management (HCVM)
Healthy Start
Humana/Choice Care PPO
Medicaid
Medicare
Neighborhood Health Plan - ACD
Neighborhood Health Plan - PBO
Network Health
OSW - Maine
OSW - New Hampshire
OSW - Rhode Island
Private Health Care Systems (PHCS)
Railroad Medicare
Railroad Medicare - ACD
TriCare
Tufts Health Plan
Tufts Medicare Advantage PPO
Unicare
United Healthcare (non-HMO) - ACD
United Healthcare (non-HMO) - PBO
Biography
Dr. Ellisen is a practicing oncologist and researcher at the Massachusetts General Hospital Cancer Center, an Associate Professor of Medicine at Harvard Medical School, and co-Executive Director of the Cancer Center's Translational Research Laboratory (TRL). He received his undergraduate degree from Harvard University, MD and PhD degrees from Stanford University, and completed residency training, oncology fellowship training, and postdoctoral research training at Brigham and Women's Hospital, the Dana-Farber Cancer Institute, and Mass General, respectively. Dr. Ellisen is widely published in the field of cancer biology and cancer genetics. His basic research efforts focus on chemosensitivity in breast and other cancers. His work in the TRL focuses on the clinical application of tumor genetic testing to advance the goal of personalized medicine. He serves on numerous grant review committees and editorial boards, and his work on personalized cancer medicine has been featured in the news media including the Wall Street Journal and the ABC Evening News.
ResearchOur research group is broadly interested in how genetic abnormalities within cancer cells influence their biology, and how that biology can in turn be exploited to therapeutic advantage. We address these questions through basic research studies of key tumor cell signaling pathways including p53, mTOR, and BRCA1/2. This work is complemented by genetic analysis of patient tumor samples conducted through our companion laboratory, the Mass General Cancer Center's Translational Research Laboratory (TRL). Finally, our discoveries in both the basic laboratory and the TRL are being applied in ongoing clinical trials which seek to identify predictive markers for response to specific therapeutic agents. Our ability to work at the interface of basic tumor biology and therapeutic application is strongly supported by the research and clinical infrastructure of the Cancer Center.
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-6500
Mass General Cancer Center at Emerson Hospital
133 Old Rd to Nine Acre Corner
Concord, MA 01742
Phone: 978-287-3436
Fax: 978-287-3642
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.